# OnCo record nano2 (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/nano2/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "nano2" ;
  schema:name "NanO2"@en ;
  schema:alternateName "dodecafluoropentane emulsion"@en, "DDFPe"@en ;
  schema:description "NanO2 is an oxygen-carrying infusion from NuvOx Therapeutics, given alongside radiotherapy to make it work better in tumours that are short of oxygen. It is in a trial in newly diagnosed glioblastoma."@en ;
  schema:url <https://onco.cc/drugs/nano2/> ;
  schema:dateModified "2026-11-04"^^xsd:date ;
  schema:citation <https://www.sec.gov/Archives/edgar/data/1966126/000121390026113463/ea0225257-14.htm>, <https://clinicaltrials.gov/study/NCT03862430> ;
  onco:status "phase-2" ;
  onco:tag "pipeline" ;
  onco:modality "Intravenous oxygen therapeutic used as a radiosensitiser (dodecafluoropentane emulsion)" ;
  onco:cancers <https://onco.cc/cancers/glioblastoma/> ;
  onco:technologies <https://onco.cc/technologies/radiosensitisers/> ;
  onco:companies <https://onco.cc/companies/nuvox-therapeutics/> ;
  onco:trials <https://onco.cc/trials/nct03862430/> .